Zobrazeno 1 - 10
of 18
pro vyhledávání: '"Rosanne W. Wieten"'
Autor:
Rosanne W Wieten, Emile F F Jonker, Ester M M van Leeuwen, Ester B M Remmerswaal, Ineke J M Ten Berge, Adriëtte W de Visser, Perry J J van Genderen, Abraham Goorhuis, Leo G Visser, Martin P Grobusch, Godelieve J de Bree
Publikováno v:
PLoS ONE, Vol 11, Iss 3, p e0149871 (2016)
INTRODUCTION:Prompted by recent amendments of Yellow Fever (YF) vaccination guidelines from boost to single vaccination strategy and the paucity of clinical data to support this adjustment, we used the profile of the YF-specific CD8+ T-cell subset pr
Externí odkaz:
https://doaj.org/article/2202956733754a58ade553da704c1aaa
Autor:
Benjamin J Visser, Rik B. J. Kraan, Lídia Ciudad Aguilar, Petra F. Mens, Selidji T Agnandji, Rosanne W. Wieten, Martin P. Grobusch, Michèle van Vugt, Peter G. Kremsner, Sophia G de Vries, Rieke Vingerling, François Danion, Martin Gritter, Daniëlle Kroon, Thomas Hänscheid, Barbara Sjouke, A.A. Adegnika
Publikováno v:
American journal of tropical medicine and hygiene, 96(5), 1205-1214. American Society of Tropical Medicine and Hygiene
The serum lipid profile in malaria patients has been found to differ from that of healthy controls. We investigated serum lipid profile changes in malaria patients over time compared with patients with other febrile diseases. In total, 217 patients w
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9b01b589f344aa23eb9141b128624662
https://europepmc.org/articles/PMC5417218/
https://europepmc.org/articles/PMC5417218/
Autor:
Abraham Goorhuis, Tjalling Leenstra, Rosanne W. Wieten, M. van Vugt, Martin P. Grobusch, Cornelis Stijnis, P. P. A. M. van Thiel
Publikováno v:
Clinical infectious diseases, 56(3), 414-419. Oxford University Press
Rabies is a deadly disease, and current preexposure vaccination schedules are lengthy and expensive. We identified nine studies investigating abbreviated schedules. Although initial responses were lower, accelerated adequate immune responses were eli
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::68b1cdb7d550468497bac903495fc64a
https://doi.org/10.1093/cid/cis853
https://doi.org/10.1093/cid/cis853
Autor:
P.J.J. Van Genderen, Martin P. Grobusch, A.W. de Visser, Abraham Goorhuis, E. van Leeuwen, G. J. de Bree, Leo G. Visser, Ester B. M. Remmerswaal, I. J. M. ten Berge, Rosanne W. Wieten, Emile F.F. Jonker
Publikováno v:
Journal of Infection, 72(6), 713-722. W B SAUNDERS CO LTD
Journal of infection, 72(6), 713-722. W.B. Saunders Ltd
Journal of infection, 72(6), 713-722. W.B. Saunders Ltd
Summary Background The 17D live attenuated yellow fever (YF) vaccine is contra-indicated in immune-compromised individuals and may elicit a suboptimal immunologic response. The aim of this study is to assess whether long-term immune responses against
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ac930e163765c1cdc768da9d5b335ef4
https://hdl.handle.net/1887/99366
https://hdl.handle.net/1887/99366
Autor:
Perry J.J. van Genderen, Abraham Goorhuis, Godelieve J. de Bree, Emile F.F. Jonker, Ester B. M. Remmerswaal, Martin P. Grobusch, Ineke J. M. ten Berge, Ester M. M. van Leeuwen, Leo G. Visser, Adriëtte W. de Visser, Rosanne W. Wieten
Publikováno v:
PLoS ONE
PLoS ONE, 11(3). Public Library of Science
PLoS ONE, 11(3). PUBLIC LIBRARY SCIENCE
PLoS ONE, Vol 11, Iss 3, p e0149871 (2016)
PLoS ONE, 11(3). Public Library of Science
PLoS ONE, 11(3). PUBLIC LIBRARY SCIENCE
PLoS ONE, Vol 11, Iss 3, p e0149871 (2016)
Introduction Prompted by recent amendments of Yellow Fever (YF) vaccination guidelines from boost to single vaccination strategy and the paucity of clinical data to support this adjustment, we used the profile of the YF-specific CD8+ T-cell subset pr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::53e9e0dd606839c004ddb523cb8d8937
https://hdl.handle.net/1887/99323
https://hdl.handle.net/1887/99323
Autor:
Martin P. Grobusch, Caspar J. Hodiamont, Emile F.F. Jonker, Abraham Goorhuis, Leo G. Visser, Eric C. M. van Gorp, Rosanne W. Wieten, Adriëtte W. de Visser, Daan K.J. Pieren, Pieter P. A. M. van Thiel
Publikováno v:
Vaccine, 34(10), 1247-1251. Elsevier BV
Vaccine, 34(10), 1247-1251. ELSEVIER SCI LTD
Vaccine, 34(10), 1247-1251. Elsevier
Vaccine, 34(10), 1247-1251. ELSEVIER SCI LTD
Vaccine, 34(10), 1247-1251. Elsevier
Background The 17D-yellow fever (YF) vaccination is considered contraindicated in immune-compromised patients; however, accidental vaccination occurs. In this population, measuring the immune response is useful in clinical practice. Methods In this s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bfdbeffcde2b2838042b780b28d49d62
https://hdl.handle.net/1887/99319
https://hdl.handle.net/1887/99319
Publikováno v:
Journal of travel medicine, 19(2), 104-110. Wiley-Blackwell
Background. Traveling the world may result in infection with tropical or other travel-associated diseases. This applies increasingly also to people with immune-compromising and other medical conditions, as well as to elderly individuals. To reduce ex
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f4b60e0ecb49eb097eeca6312b9ad4bb
https://doi.org/10.1111/j.1708-8305.2011.00594.x
https://doi.org/10.1111/j.1708-8305.2011.00594.x
Autor:
Martin P. Grobusch, Elie G. Rossatanga, Sabine Bélard, Rosanne W. Wieten, Sebastiaan M. Stolp, Anne Lia Cremers, Saskia Janssen, Kerstin Klipstein-Grobusch
Publikováno v:
PLoS One
PLoS ONE
PLoS ONE [E], 10(10), e0140746. Public Library of Science
PLoS ONE, 10(10). Public Library of Science
PLoS ONE, Vol 10, Iss 10, p e0140746 (2015)
PLoS ONE
PLoS ONE [E], 10(10), e0140746. Public Library of Science
PLoS ONE, 10(10). Public Library of Science
PLoS ONE, Vol 10, Iss 10, p e0140746 (2015)
Background Retention to HIV care is vital for patients’ survival, to prevent onward transmission and emergence of drug resistance. Travelling to receive care might influence adherence. Data on the functioning of and retention to HIV care in the Cen
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e33f6c963eb65a0b8edb8ad90ac59204
http://hdl.handle.net/11427/15919
http://hdl.handle.net/11427/15919
Autor:
Ingeborg M. Nagel, Rosanne W. Wieten, Sabine Bélard, Daniëlle Kroon, Benjamin J Visser, Martin P. Grobusch, Michèle van Vugt
Publikováno v:
Malaria Journal
Background Artemisinin combination therapy (ACT) is recommended as first-line treatment for uncomplicated Plasmodium falciparum malaria, whereas chloroquine is still commonly used for the treatment of non-falciparum species (Plasmodium vivax, Plasmod
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c72e1996498b1e17fe7854ecd070d257
https://doi.org/10.1186/1475-2875-13-463
https://doi.org/10.1186/1475-2875-13-463
Publikováno v:
Journal of infectious diseases, 212(3), 378-385. Oxford University Press
Background Hepatitis A vaccines are highly immunogenic in healthy patients, but there is uncertainty about their immunogenicity in immunocompromised patients. Methods Our study included immunocompromised patients who received 1 or 2 hepatitis A vacci
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5108cfd8b63c0da104ba39cdb7ee2c22
https://pubmed.ncbi.nlm.nih.gov/25649170
https://pubmed.ncbi.nlm.nih.gov/25649170